{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:26:47Z","timestamp":1793064407683,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015722","name":"Centre Hospitalier Universitaire de Clermont-Ferrand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"French National Cancer Institute","doi-asserted-by":"publisher","award":["PHRC2008"],"award-info":[{"award-number":["PHRC2008"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijrobp.2025.07.1442","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:07:29Z","timestamp":1753974449000},"page":"109-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized Trial"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5675-9989","authenticated-orcid":false,"given":"Celine","family":"Bourgier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mollevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Castan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lemanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gourgou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Labib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Peignaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali Le","family":"Blanc-Onfroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Benyoucef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Mege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zineb","family":"Douadi-Gaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Racadot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Latorzeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Jacquot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Massabeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Geffrelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lecouillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Breton-Callu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Richard-Tallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatiha","family":"Boulbair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Belliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Magn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazid","family":"Belkac\u00e9mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Bons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Fenoglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Azria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0001","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"2010","author":"Correa","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0003","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1470-2045(06)70765-3","article-title":"Boost radiotherapy in young women with ductal carcinoma in situ: A multicentre, retrospective study of the rare cancer network","volume":"7","author":"Omlin","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0004","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1078-0432.CCR-07-1465","article-title":"Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast","volume":"14","author":"Vincent-Salomon","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.canrad.2008.07.005","article-title":"Radioth\u00e9rapie des carcinomes canalaires in situ: Impact du compl\u00e9ment d\u2019irradiation du lit tumoral [Ductal carcinoma in situ: Role of the boost]","volume":"12","author":"Azria","year":"2008","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0006","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2021.09.014","article-title":"Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ","volume":"164","author":"Bourgier","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0007","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0008","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). v 3.0. DCTD, NCI, NIH, DHHS."},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0009","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0010","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1200\/JCO.1996.14.10.2756","article-title":"The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: First results from a three-country field study","volume":"14","author":"Sprangers","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0011","series-title":"EORTC QLQ-C30 Scoring Manual","author":"Fayers","year":"2001"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0012","first-page":"399","article-title":"Quality of life of women treated with radiotherapy for breast cancer","volume":"16","author":"Lee","year":"2008","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0013","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1470-2045(20)30085-1","article-title":"Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07\/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial","volume":"21","author":"King","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0014","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1200\/JCO.2014.56.7974","article-title":"Statistical challenges in the analysis of health-related quality of life in cancer clinical trials","volume":"34","author":"Bonnetain","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11136-020-02605-3","article-title":"Longitudinal analysis of health-related quality of life in cancer clinical trials: Methods and interpretation of results","volume":"30","author":"Bascoul-Mollevi","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0016","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","article-title":"Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30","volume":"29","author":"Cocks","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0017","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11136-013-0583-6","article-title":"Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: Do we need RECIST for quality of life to achieve standardization?","volume":"24","author":"Anota","year":"2015","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0018","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: The consort pro extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0019","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(11)61256-7","article-title":"Reporting quality of life in clinical trials: A consort extension","volume":"378","author":"Calvert","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2018.11.024","article-title":"General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States","volume":"107","author":"Nolte","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0021","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(22)01246-6","article-title":"Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07\/TROG 07.01): A randomised, factorial, multicentre, open-label, phase 3 study","volume":"400","author":"Chua","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0022","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJMoa010874","article-title":"Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation","volume":"345","author":"Bartelink","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0023","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1200\/JCO.2007.11.4991","article-title":"Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial","volume":"25","author":"Bartelink","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0024","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ebiom.2015.10.024","article-title":"Radiation-induced CD8 T-lymphocyte apoptosis as a predictor of breast fibrosis after radiotherapy: Results of the prospective multicenter french trial","volume":"2","author":"Azria","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0025","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.bjc.6602146","article-title":"Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients","volume":"91","author":"Azria","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0026","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2004.00.8623","article-title":"Radiation therapy and tamoxifen: Concurrent or sequential? It\u2019s no longer the question!","volume":"23","author":"Azria","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0027","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1200\/JCO.2005.01.198","article-title":"Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer","volume":"23","author":"Pierce","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0028","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1470-2045(10)70013-9","article-title":"Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): A phase 2 randomised trial","volume":"11","author":"Azria","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6745954","article-title":"Factors associated with late local radiation toxicity after post-operative breast irradiation","volume":"2022","author":"Batenburg","year":"2022","journal-title":"Breast J"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0030","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ejca.2008.07.032","article-title":"Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: A study based on the EORTC trial 22881-10882 \u2018boost versus no boost\u2019","volume":"44","author":"Collette","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104269","article-title":"Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort","volume":"84","author":"Webb","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109806","article-title":"Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer","volume":"187","author":"Jandu","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0033","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41687-017-0008-3","article-title":"A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: Implications for generalisability and clinical practice","volume":"1","author":"Mercieca-Bebber","year":"2017","journal-title":"J. Patient Rep Outcomes."},{"key":"10.1016\/j.ijrobp.2025.07.1442_bib0034","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11136-022-03252-6","article-title":"Flexible modeling of longitudinal health-related quality of life data accounting for informative dropout in a cancer clinical trial","volume":"32","author":"Winter","year":"2023","journal-title":"Qual Life Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625060389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625060389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:49:38Z","timestamp":1791654578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625060389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0360301625060389"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.07.1442","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.07.1442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}